Add to ORKGnumber of malignancies. However, only a portion of ability to predict responses to chemotherapy; for ex-Chen et al. BMC Medical Genomics 2012, 5:4
<p>Results are presented as n (%) of 33 patients for the whole-genome expression analysis cohort and...
Full list of author information is available at the end of the articleleukemia cells is a complex ph...
Advances in cancer medicine have traditionally come from detailed understanding of biological proces...
is available at the end of the articleBackground Patients suffering from cancer are usually treated ...
n-lth RN lu of ty tosis [10,11], carcinogenesis [12-14], and response to dif- portant features which...
Full list of author information is available at the end of the articleogenous factors, and is consid...
A randomized, phase 2 study comparing at a one-sided alpha of 0.2. Secondary endpoints: response and...
en no R many cancers, with more than 60 % of new cancers and [12-18]. Very little data exist on the ...
Developing reliable biomarkers of tumor cell drug sensitivity and resistance can guide hypothesis-dr...
, P e ls se majority of cancers and it was reported that approximately 80 % of cervical cancers and ...
Tailoring treatment to the unique cancer of each individual patient is important to improve patient ...
Neoadjuvant chemotherapy for breast cancer provides critical information about tumor response; how b...
Full list of author information is available at the end of the articleOvarian cancer remains leading...
Full list of author information is available at the end of the articleBackground Breast cancer is on...
id 80 % of pediatric leukemias [1]. The disease is character- fication of additional markers which w...
<p>Results are presented as n (%) of 33 patients for the whole-genome expression analysis cohort and...
Full list of author information is available at the end of the articleleukemia cells is a complex ph...
Advances in cancer medicine have traditionally come from detailed understanding of biological proces...
is available at the end of the articleBackground Patients suffering from cancer are usually treated ...
n-lth RN lu of ty tosis [10,11], carcinogenesis [12-14], and response to dif- portant features which...
Full list of author information is available at the end of the articleogenous factors, and is consid...
A randomized, phase 2 study comparing at a one-sided alpha of 0.2. Secondary endpoints: response and...
en no R many cancers, with more than 60 % of new cancers and [12-18]. Very little data exist on the ...
Developing reliable biomarkers of tumor cell drug sensitivity and resistance can guide hypothesis-dr...
, P e ls se majority of cancers and it was reported that approximately 80 % of cervical cancers and ...
Tailoring treatment to the unique cancer of each individual patient is important to improve patient ...
Neoadjuvant chemotherapy for breast cancer provides critical information about tumor response; how b...
Full list of author information is available at the end of the articleOvarian cancer remains leading...
Full list of author information is available at the end of the articleBackground Breast cancer is on...
id 80 % of pediatric leukemias [1]. The disease is character- fication of additional markers which w...
<p>Results are presented as n (%) of 33 patients for the whole-genome expression analysis cohort and...
Full list of author information is available at the end of the articleleukemia cells is a complex ph...
Advances in cancer medicine have traditionally come from detailed understanding of biological proces...